Application 017476
- Type
- NDA
- Sponsor
- NOVARTIS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 002 | SLOW-K | POTASSIUM CHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 8MEQ | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N017476-002 | SLOW-K | POTASSIUM CHLORIDE | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | Approved before 1982 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N017476-002 | SLOW-K | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | Approved before 1982 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | N017476-002 | SLOW-K | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | Approved before 1982 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N017476-002 | SLOW-K | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | Approved before 1982 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N017476-002 | SLOW-K | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | Approved before 1982 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N017476-002 | SLOW-K | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | Approved before 1982 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N017476-002 | SLOW-K | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | Approved before 1982 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N017476-002 | SLOW-K | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | Approved before 1982 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N017476-002 | SLOW-K | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | Approved before 1982 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N017476-002 | SLOW-K | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | Approved before 1982 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N017476-002 | SLOW-K | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | Approved before 1982 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N017476-002 | SLOW-K | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | Approved before 1982 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | N017476-002 | SLOW-K | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | Approved before 1982 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N017476-002 | SLOW-K | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | Approved before 1982 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N017476-002 | SLOW-K | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | Approved before 1982 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N017476-002 | SLOW-K | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | Approved before 1982 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | N017476-002 | SLOW-K | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | Approved before 1982 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N017476-002 | SLOW-K | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | Approved before 1982 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N017476-002 | SLOW-K | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | Approved before 1982 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | N017476-002 | SLOW-K | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | Approved before 1982 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N017476-002 | SLOW-K | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | Approved before 1982 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | N017476-002 | SLOW-K | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | Approved before 1982 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | N017476-002 | SLOW-K | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | Approved before 1982 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N017476-002 | SLOW-K | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | Approved before 1982 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | N017476-002 | SLOW-K | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | Approved before 1982 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N017476-002 | SLOW-K | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | Approved before 1982 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N017476-002 | SLOW-K | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | Approved before 1982 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N017476-002 | SLOW-K | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | Approved before 1982 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | N017476-002 | SLOW-K | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | Approved before 1982 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | N017476-002 | SLOW-K | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | Approved before 1982 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N017476-002 | SLOW-K | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | Approved before 1982 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | N017476-002 | SLOW-K | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | Approved before 1982 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | N017476-002 | SLOW-K | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | Approved before 1982 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N017476-002 | SLOW-K | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | Approved before 1982 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N017476-002 | SLOW-K | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | Approved before 1982 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N017476-002 | SLOW-K | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | Approved before 1982 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N017476-002 | SLOW-K | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | Approved before 1982 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | N017476-002 | SLOW-K | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | Approved before 1982 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | N017476-002 | SLOW-K | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | Approved before 1982 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N017476-002 | SLOW-K | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | Approved before 1982 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | N017476-002 | SLOW-K | 8MEQ | TABLET, EXTENDED RELEASE / ORAL | Approved before 1982 | f41ea6bd6efb… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Potassium Chloride | POTASSIUM CHLORIDE | Actavis Pharma, Inc. | ed5baaf6-270b-4dd3-b100-36030c0098fc | 2022-08-01 | Warnings, Adverse reactions | POTASSIUM CHLORIDE |
| KALIUM MURIATICUM 6X | POTASSIUM CHLORIDE | Seroyal USA | 22c95b6a-dd5d-476e-e054-00144ff8d46c | 2022-07-07 | Warnings | POTASSIUM CHLORIDE |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | B. Braun Medical Inc. | ab67b151-8368-4321-b562-bad5eff7b740 | 2022-02-21 | Warnings, Adverse reactions | POTASSIUM CHLORIDE |
| Potassium Chloride | POTASSIUM CHLORIDE | Tris Pharma Inc | 159ddd0b-847e-4ecc-b3b2-9634cbb4dfa9 | 2022-01-26 | Warnings, Adverse reactions | POTASSIUM CHLORIDE |
| Potassium Chloride | POTASSIUM CHLORIDE | Guardian Drug Company | 3d460e84-27a0-485c-8b11-58d03d9064aa | 2021-07-28 | Warnings, Adverse reactions | POTASSIUM CHLORIDE |
| Potassium Chloride | POTASSIUM CHLORIDE | Aurobindo Pharma Limited | deb6b462-397f-4527-ae26-40dc5d5857bc | 2021-04-30 | Warnings, Adverse reactions | POTASSIUM CHLORIDE |
| Potassium Chloride | POTASSIUM CHLORIDE | Aurobindo Pharma Limited | d43beabe-b801-4319-ad36-9a80856b94bd | 2021-04-29 | Warnings, Adverse reactions | POTASSIUM CHLORIDE |
| potassium chloride | POTASSIUM CHLORIDE | Zydus Pharmaceuticals (USA) Inc. | 51586c47-1aff-4ce6-8030-89f9eb1bc9ac | 2021-02-08 | Warnings, Adverse reactions | POTASSIUM CHLORIDE |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | Lupin Pharmaceuticals,Inc. | 28c49165-d8c9-443a-b000-953b8e1ec55c | 2020-11-20 | Warnings, Adverse reactions | POTASSIUM CHLORIDE |
| Potassium Chloride | POTASSIUM CHLORIDE | Genus Lifesciences Inc. | 23d818e7-c076-40de-8dc1-0b51ba4be96a | 2020-04-28 | Warnings, Adverse reactions | POTASSIUM CHLORIDE |
| Potassium Chloride | POTASSIUM CHLORIDE | Lupin Pharmaceuticals,Inc. | 1bbacdbb-91fa-4897-a00c-1b293de27b83 | 2020-04-27 | Warnings, Adverse reactions | POTASSIUM CHLORIDE |
| Potassium Chloride | POTASSIUM CHLORIDE | Mylan Pharmaceuticals Inc. | c64ed4c0-1e27-42b3-9625-fb4e0d31e271 | 2020-04-15 | Warnings, Adverse reactions | POTASSIUM CHLORIDE |
| Potassium Chloride | POTASSIUM CHLORIDE | BluePoint Laboratories | 431ff2ef-567c-4b60-af43-f4da61febaad | 2019-07-03 | Warnings, Adverse reactions | POTASSIUM CHLORIDE |
| Potassium Chloride | POTASSIUM CHLORIDE | Novel Laboratories, Inc. | ce4d4d39-8551-4789-8347-af763635922c | 2018-11-28 | Warnings, Adverse reactions | POTASSIUM CHLORIDE |
| Potassium Chloride | POTASSIUM CHLORIDE | Northstar Rx LLC | dded25a9-3df4-463a-8685-d2bc03ea4edb | 2018-07-16 | Warnings, Adverse reactions | POTASSIUM CHLORIDE |
| Potassium Chloride | POTASSIUM CHLORIDE | Glenmark Pharmaceuticals Inc., USA | 5b054142-7372-4641-be27-dca630a97ad9 | 2016-04-29 | Warnings, Adverse reactions | POTASSIUM CHLORIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.